Dawn Mattoon

Dawn Mattoon has extensive work experience in the biotech industry, starting as a Scientist in Protometrix in 2004, and advancing to Senior Scientist, R&D Manager, Director of Program Management, Senior Director of Global Program & Portfolio Management, and Senior Director of Strategy while at Life Technologies from 2004 to 2014. In 2014, they joined Cell Signaling Technology (CST) as Vice President of Product Development and later joined Quanterix as Senior Vice President of Strategic Marketing & Assay Technologies in 2018. In 2022, they became the Chief Operating Officer of Mercy BioAnalytics, and one year later, was promoted to Chief Executive Officer.

Dawn Mattoon received their Bachelor of Arts degree in Biology from Bard College in 1994. From 1997 to 2001, they pursued their Ph.D. in Genetics from Yale University.